Moderna and Merck said on Tuesday their ⁠experimental personalized vaccine continued to cut the risk of death or recurrence of the most dea...

New research suggests COVID-19 mRNA vaccines could help cancer patients. Those with advanced lung or skin cancer who received Pfizer or Mod...

Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inh...

Cancer Vaccine: A new mRNA cancer vaccine developed by Moderna has shown promising early results in clinical trials. The vaccine, mRNA-4359...

Moderna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and ...

Russian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines, potentially revolutionizing can...

Cancer patients in the UK are part of a global trial for the mRNA therapy mRNA-4359. The phase 1/2 clinical trial, sponsored by Moderna, ai...

Decades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.

Data revealed that using Merck's immunotherapy drug in combination with high-risk patients decreased their risk of dying.

At a press briefing in Geneva on Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus said the new hub will be in South Korea and wil...

Moderna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...

The new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...

Earlier this month, Pfizer Inc and partner BioNTech SE said their vaccine using similar messenger RNA (mRNA) technology remained highly eff...

"Based on the data to date, we expect that the Moderna vaccine-induced immunity would be protective against the variants recently described...

Wipro founder-chairman Azim Premji owns a minority stake in US biotech company Moderna, which is developing a vaccine that could potentiall...

Wipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.

Novel cancer drugs often come with six-figure price tags, so success could be lucrative. Numerous companies are chasing a cancer vaccine. O...